Protein-based materials intended as nanostructured drugs or drug carriers are progressively gaining interest in nanomedicine. since their structure. assembly and cellular interactivity can be tailored by recruiting functional domains. The main bottleneck in the development of deliverable protein materials is the lysosomal degradation that follows endosome maturation. https://darthomes.shop/product-category/garden-sculptures/